Skip to content
Open access

IN SILICON EVALUATION OF ARTEMISININ DERIVATIVES AS POTENTIAL INHIBITORS OF SARS-COV-2 MAIN PROTEASE

Jul 2026 · Перспективи та інновації науки · 0 citations

TL;DR

Four artemisinin-derived compounds namely, artesunate, artemether, artemisinin and dihydroartemisinin were evaluated as potential Mpro binders using molecular docking and post docking interaction analysis and among the tested ligands, artesunate showed the most favorable predicted binding affinity with docking score.

Abstract

. The main protease of SARS-CoV-2 (Mpro, 3CLpro) is a crucial viral enzyme required for the cleavage of viral polyproteins during coronavirus replication. Its catalytic activity relies on the conserved His41–Cys145 dyad, making the main protease (Mpro) an important molecular target for the discovery of antiviral drugs. In the present study, four artemisinin-derived compounds namely, artesunate, artemether, artemisinin and dihydroartemisinin were evaluated as potential Mpro binders using molecular docking and post docking interaction analysis . Docking simulations were performed using the crystal structure of SARS-CoV-2 Mpro and AutoDock Vina. The docking grid was centered on the catalytic pocket defined by His41 and Cys145. The generated poses were assessed based on predicted affinity, proximity to catalytic residues, hydrogen bond-like O/N contacts, hydrophobic C–C contacts, and multivariate interaction profiles. Among the tested ligands, artesunate showed the most favorable predicted binding affinity with docking score

Read PDF

Similar papers

Open access Jul 2026

Identifying and Evaluating Flavonoids as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro/3CL) Through Docking and Molecular Dynamics

Findings highlight glycosylated flavonoids as promising scaffolds for future structure-based optimization and provide structural insights to guide experimental validation.

Getulio Flores-Tlalpa, L. Domínguez-Ramírez, Luis Márquez-Domínguez et al. · 0 citations
Open access Sep 2026

Natural Metabolites from Clinacanthus nutans as Promising SARS-CoV-2 Main Protease Inhibitors: Insights from Molecular Docking and Dynamics Simulations

Overall, vitexin shows promising binding characteristics as a natural compound targeting Mpro, but it does not surpass the native ligand in terms of overall binding stability, warranting further optimization and experimental validation.

Syahida Djasang, Artati Artati · 0 citations
Sep 2026

Identification of potential SARS-CoV-2 Mpro inhibitors from a Thai natural product database via interaction fingerprint-based virtual screening

It is revealed that the S2 binding site serves as a key region to anchor most non-covalent inhibitors of SARS-CoV-2 Mpro, which is a promising target for coronavirus disease 2019 (COVID-19) therapy.

Aunlika Chimprasit, G. Bret, S. Hannongbua et al. · 0 citations
Open access Aug 2026

Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches

The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.

Mohd Yasir Khan, Farah Maarfi, A. Shah et al. · 0 citations
Sep 2026

Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors: An In Silico Approach.

The docking, ADMET, and MD simulation studies indicate that the designed shikimic acid derivatives have good binding affinity and drug-like properties, and are stable in the active site of the SARS-CoV-2 main protease.

Hardha Balachandran, Kaviarasan Lakshmanan, Dipen Purohit et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.